PWM
MRK icon

Parkworth Wealth Management’s Merck MRK Stock Holding History

Parkworth Wealth Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$54K Buy
682
+49
+8% +$3.9K 0.04% 99
2025
Q1 		$56.8K Buy
633
+5
+0.8% +$467 0.05% 89
2024
Q4 		$62.5K Buy
+628
New +$64.7K 0.05% 85

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Parkworth Wealth Management's MRK Position: Q2 2025 in Review

Parkworth Wealth Management increased its Merck (MRK) stake by 7.7% in Q2 2025, buying an estimated $3.9K and bringing the position to 682 shares worth $54K. The position accounts for 0.04% of the portfolio, ranked #99.

Parkworth Wealth Management first reported a position in MRK in Q4 2024 and has held it in 3 quarters since. The position peaked at $62.5K in Q4 2024. 3,327 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

  • Parkworth Wealth Management held 682 shares of Merck worth $54K as of Q2 2025.
  • Parkworth Wealth Management bought 49 Merck shares in Q2 2025, an estimated $3.9K.
  • Merck made up 0.04% of Parkworth Wealth Management's portfolio in Q2 2025, its #99 holding.
  • Parkworth Wealth Management first reported a position in Merck in Q4 2024 and has held it in 3 quarters since.
  • Parkworth Wealth Management's Merck position peaked at $62.5K in Q4 2024.
  • 3,327 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on Parkworth Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.